Correlation Engine 2.0
Clear Search sequence regions


  • apoptosis (1)
  • ATF4 (1)
  • CRYAB (1)
  • CYP2E1 (1)
  • DDIT3 (3)
  • deuterium oxide (3)
  • factor (4)
  • firefly (1)
  • HMOX1 (1)
  • HSPA1A (1)
  • HSPA8 (1)
  • human (3)
  • immunoblot (1)
  • mice (1)
  • NFKBIA (1)
  • NOS2 (1)
  • oxide (1)
  • pancreatic ductal adenocarcinoma (5)
  • pcna (1)
  • plasma (1)
  • proton (1)
  • PTGS1 (1)
  • PTGS2 (1)
  • redox (1)
  • research (1)
  • reticulum (2)
  • RUNX1 (2)
  • scid mice (3)
  • SOD2 (1)
  • tumor burden (1)
  • XBP1s (1)
  • xenograft (1)
  • Sizes of these terms reflect their relevance to your search.

    Since its initial discovery as a natural isotopologue of dihydrogen oxide (1 H2 O), extensive research has focused on the biophysical, biochemical, and pharmacological effects of deuterated water (2 H2 O [D2 O, also referred to as "heavy water"]). Using a panel of cultured human pancreatic ductal adenocarcinoma (PDAC) cells we have profiled (i) D2 O-induced phenotypic antiproliferative and apoptogenic effects, (ii) redox- and proteotoxicity-directed stress response gene expression, and (iii) phosphoprotein-signaling related to endoplasmic reticulum (ER) and MAP-kinase stress response pathways. Differential array analysis revealed early modulation of stress response gene expression in both BxPC-3 and PANC-1 PDAC cells elicited by D2 O (90%; ≤6 h; upregulated: HMOX1, NOS2, CYP2E1, CRYAB, DDIT3, NFKBIA, PTGS1, SOD2, PTGS2; downregulated: RUNX1, MYC, HSPA8, HSPA1A) confirmed by independent RT-qPCR analysis. Immunoblot-analysis revealed rapid (≤6 h) onset of D2 O-induced MAP-kinase signaling (p-JNK, p-p38) together with ER stress response upregulation (p-eIF2α, ATF4, XBP1s, DDIT3/CHOP). Next, we tested the chemotherapeutic efficacy of D2 O-based drinking water supplementation in an orthotopic PDAC model employing firefly luciferase-expressing BxPC-3-FLuc cells in SCID mice. First, feasibility and time course of systemic deuteration (30% D2 O in drinking water; 21 days) were established using time-resolved whole-body proton magnetic resonance imaging and isotope-ratio mass spectrometry-based plasma (D/H)-analysis. D2 O-supplementation suppressed tumor growth by almost 80% with downregulated expression of PCNA, MYC, RUNX1, and HSP70 while increasing tumor levels of DDIT3/CHOP, HO-1, and p-eIF2α. Taken together, these data demonstrate for the first time that pharmacological induction of systemic deuteration significantly reduces orthotopic tumor burden in a murine PDAC xenograft model. © 2023 The Authors. Molecular Carcinogenesis published by Wiley Periodicals LLC.

    Citation

    Jana Jandova, Jean-Philippe Galons, David L Dettman, Georg T Wondrak. Systemic deuteration of SCID mice using the water-isotopologue deuterium oxide (D2 O) inhibits tumor growth in an orthotopic bioluminescent model of human pancreatic ductal adenocarcinoma. Molecular carcinogenesis. 2023 May;62(5):598-612

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 36727657

    View Full Text